Blar i Institutt for klinisk og molekylær medisin på tidsskrift "European Urology"
Viser treff 1-1 av 1
-
Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death—Results from the Norwegian Prostate Cancer Consortium
(Peer reviewed; Journal article, 2023)Background Prostate-specific antigen (PSA) levels in midlife are strongly associated with the long-term risk of lethal prostate cancer in cohorts not subject to screening. This is the first study evaluating the association ...